why choose us

First received: January 03, 2024

Clinical Trial: An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men With Nonmetastatic Prostate Cancer in Routine Medical Care in the United States

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-metastatic Prostate Cancer

Study Type: OBSERVATIONAL


Official Title: ARI Treatment Use and Outcomes in Non-metastatic Prostate Cancer (nmPC) Patients in the US

Brief Summary: This is an observational study in which data will be collected and studied from men with non-metastatic prostate cancer (nmPC) who received their usual treatment with 'androgen receptor inhibitors' (ARIs) including darolutamide, enzalutamide, and apalutamide.Prostate cancer is a common cancer in men that starts in the prostate gland, a male reproductive gland found below the bladder.Non-metastatic means that cancer has not yet spread to other parts of the body.Darolutamide, enzalutamide, and apalutamide…

Read more